Jeffrey W. Albers, Director at Blueprint Medicines Corp (BPMC), sold 22,066 shares at $90.69 ($2.0M) on 2024-03-07, disclosed to the SEC on 2024-03-26.
Seasonal sale ($2.0M) by Director — this insider has traded BPMC in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.69 | 11,033 | $1.0M | 50.0% |
| 2 | $90.69 | 11,033 | $1.0M | 50.0% |
| Total | $90.69 avg | 22,066 | $2.0M | 100% |
| Filing → |
| KYMR | SELL | 2025-10-14 | $296K | — | Filing → |
| KYMR | SELL | 2025-06-03 | $311K | — | Filing → |
| BPMC | SELL | 2025-05-29 | $572K | — | Filing → |